Category Archives: Uncategorized

This morning Sleepio co-founder Peter Hames was invited back onto BBC World Service for an update on the response to the World Sleep Survey following Tuesday’s World Update. We saw a fantastic reaction to the survey all the way from Afganistan to Zambia, with the greatest number of responses from... Read on ›

This evening’s ITN’s Tonight program will be focusing on the “urgent need” to address insomnia, the most common sleep disorder affecting around 10% of the population.  The program will explore the varying forms of help which may be offered to those experiencing the problem and the availability of such treatments... Read on ›

This morning Sleepio’s co-founder, Peter Hames, was lucky enough to be invited onto BBC World Service’s ‘World Update’ as a guest, to talk about the World Sleep Survey. The World Sleep Survey, which aims to be the largest ever survey of the world’s sleep, was launched by Sleepio following the success... Read on ›

Last weekend The Observer ran a couple of great articles which we hope will help to further raise the profile of the Nation’s sleep problems and the need for evidence-based solutions. However we wanted to clarify and expand on some of the statistics quoted from the Great British Sleep Survey... Read on ›

A recent study published in the prestigious British Medical Journal reports that children who do not get enough sleep have an increased likelihood of becoming overweight and obese. Many previous cross-sectional and prospective studies have reported that sleeping less is associated with elevations in Body Mass Index (BMI), in both children... Read on ›

A new study, published online in the Journal of Clinical Sleep Medicine, reports findings from a trial of email-delivered cognitive behavioural therapy (CBT) for poor sleep in college students. The authors focussed on college students since they are known to have erratic sleep schedules and poor sleep quality, which could... Read on ›

A new study has systematically investigated the frequency and nature of depressive symptoms that remain in individuals with Major Depressive Disorder, despite responding favourably to the anti-depressant, Citalopram. It has been well documented that residual depressive symptoms, even for those who go into remission, increase the likelihood of future relapse.... Read on ›